Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-081949
Filing Date
2025-08-22
Accepted
2025-08-22 17:15:54
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B5 tm2524059-1_424b5.htm 424B5 431462
2 EX-FILING FEES tm2524059d1_ex-filingfees.htm   iXBRL EX-FILING FEES 25106
3 GRAPHIC lg_iovance-4c.jpg GRAPHIC 25306
  Complete submission text file 0001104659-25-081949.txt   613310

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2524059d1_ex-filingfees_htm.xml XML 4439
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-272718 | Film No.: 251247183
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)